1. The remuneration for the intra-Community acquisition of pharmaceuticals by a statutory health insurance company is based on the – discounted – amount paid by the latter to the respective mail-order pharmacy plus the manufacturer discount paid by the pharmaceutical company to the pharmacy.
2. Taking into account the manufacturer discount as part of the remuneration does not violate the principle of VAT neutrality in the case of deliveries of pharmaceuticals in a domestic supply chain – with the exception of mail order pharmacies – from a pharmaceutical company to a wholesaler and a mail order pharmacy to a statutory health insurance company.
Source: BFH, ruling v. December 10th, 2020, VR 34/18
Latest Posts in "Germany"
- VAT Issues Concerning Holiday Apartments: Tax Status, Input Tax Deduction, and Small Business Regulation
- Germany B2B E-Invoicing in 2027: Time to Prepare
- BMF Clarifies VAT Deduction Rules for Permanently Loss-Making Institutions: Two-Step Assessment Required
- Germany Publishes GEBA, Retires Old XRechnung Profiles to Boost E-Invoicing and Peppol Readiness
- Federal Court: Monthly/Quarterly and Annual VAT Returns Are Separate Acts, Not a Single Offense














